¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"intermediate trait"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intermediate trait
    Áß°£¼ºÇâ(¼ÒÁú)
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autosomal dominant trait
    º¸Åë¿°»öü¿ì¼º¼ÒÁú, »ó¿°»öü¿ì¼º¼ÒÁú
  • autosomal recessive trait
    º¸Åë¿°»öü¿­¼º¼ÒÁú, »ó¿°»öü¿­¼º¼ÒÁú
  • dominant trait
    ¿ì¼º¼ÒÁú
  • multifactorial trait
    ´ÙÀÎÀÚ¼ÒÁú
  • recessive trait
    ¿­¼º¼ÒÁú
  • sickle cell trait
    ³´ÀûÇ÷±¸¼ÒÁú, ³´¼¼Æ÷¼ºÇâ
  • intermediate
    1. Áß°£- 2. Áß°£¹°
  • intermediate body
    Áß°£¼Òü
  • intermediate care facility
    Áß°£Ä¡·á½Ã¼³
  • intermediate cell mass
    Áß°£¼¼Æ÷µ¢ÀÌ, Áß°£¼¼Æ÷±«
  • intermediate coupling
    Áß°£°áÇÕ
  • intermediate density lipoprotein
    Á߹еµÁöÁú´Ü¹éÁú
  • intermediate field magnetic resonance scanner
    ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • intermediate ganglion
    Áß°£½Å°æÀý
  • intermediate host
    Áß°£¼÷ÁÖ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intermediate host
    Áß°£¼÷ÁÖ
  • intermediate
    Áß°£-, Áß°£¹°
  • trait
    ¼ÒÁú, ¼ºÇâ
  • autosomal dominant trait
    º¸Åë¿°»öü¿ì¼º¼ÒÁú
  • autosomal recessive trait
    º¸Åë¿°»öü¿­¼º¼ÒÁú
  • sex-linked trait
    ¼º¿¬°ü¼ÒÁú, ¹Ý¼º¼ÒÁú
  • sickle cell trait
    ³´¼¼Æ÷¼ÒÁú, ³´ÀûÇ÷±¸Çü¼º¼ÒÁú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autosomal dominant trait
    º¸Åë¿°»öü¿ì¼º¼ÒÁú
  • autosomal recessive trait
    º¸Åë¿°»öü¿­¼º¼ÒÁú
  • dominant trait
    ¿ì¼º¼ÒÁú
  • hereditary trait
    À¯Àü¼ÒÁú
  • multifactorial trait
    ´ÙÀÎÀÚ¼ºÇâ
  • recessive trait
    ¿­¼º¼ÒÁú
  • sex-linked trait
    ¹Ý¼º¼ÒÁú, ¼º¿¬°á¼ÒÁú
  • sickle cell trait
    ³´¼¼Æ÷¼ÒÁú, ³´ÀûÇ÷±¸Çü¼º¼ÒÁú
  • trait
    ¼ÒÁú, ¼ºÇâ
  • intermediate body
    Áß°£¼Òü
  • intermediate coupling
    Áß°£°áÇÕ
  • intermediate care facility
    Áß°£Ä¡·á½Ã¼³
  • intermediate ganglion
    Áß°£½Å°æÀý
  • intermediate host
    Áß°£¼÷ÁÖ
  • intermediate hybrid
    Áß°£ÀâÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cooleys trait=thalassemia minor
    Äí¿ï¸®¼ÒÁú(áÈòõ)= °æÁõ¼º ÁöÁßÇØºóÇ÷
  • Hageman trait
    ÇϰԸ¸ÇüÁú
  • IDL = intermediate density lipoprotein
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • Intermediate density lipoprotein =IDL
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • Intermediate filaments
    Áß°£¼¼»ç(ñéÊàá¬Þê)
  • Intermediate part(commissura) of bulb
    Áú¾î±Í¸Á¿ïÁß°£ºÎºÐ
  • alpha-thalassemia trait
    ¾ËÆÄ-Å»¶ó¼¼¹Ì¾Æ ¼ÒÀÎ
  • gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
  • hemoglobin C trait
    CÇü ¼ÒÁú<Ư¼º
  • hemoglobin D trait
    Çì¸ð±Û·ÎÁø D ¼ÒÁú<Ư¼º
  • hemoglobin E trait
    Çì¸ð±Û·Îºó E ¼ÒÁú<Ư¼º
  • hereditary trait
    À¯Àü¼ÒÁú(ë¶îîáÈòõ).
  • inferior pontine intermediate reticular nuleus
    ¾Æ·¡´Ù¸®³úÁß°£±×¹°ÇÙ
  • personality trait
    ÀÎ°ÝÆ¯¼º(¡­÷åàõ).
  • pituitary intermediate lobe
    ³úÇϼöüÁß°£¿±, ³úÇϼöüÁß¿±(¡­ñéç¨).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alpha-thalassemia trait
    ¾ËÆÄ-Å»¶ó¼¼¹Ì¾Æ ¼ÒÀÎ
  • autosomal dominant trait
    »ó¿°»öü¿ì¼ºÀ¯ÀüÇüÁú.
  • dominant trait
    ¿ì¼º¼ÒÁú(éÐàõáÈòõ).
  • hemoglobin C trait
    CÇü ¼ÒÁú<Ư¼º
  • hemoglobin D trait
    Çì¸ð±Û·ÎÁø D ¼ÒÁú<Ư¼º
  • hemoglobin E trait
    Çì¸ð±Û·Îºó E ¼ÒÁú<Ư¼º
  • hereditary trait
    À¯Àü¼ÒÁú(ë¶îîáÈòõ).
  • multifactorial trait
    ´ÙÀÎÀÚ¼º ÇüÁú(¡­àõû¡òõ).
  • pedigree pattern of autosomal dominant trait
    »ó¿°»öü¼º ¿ì¼ºÇüÁúÀÇ °¡°èµµ(ßÈæøßäô÷àõéÐàõû¡òõ¡­Ê«Í§Óñ).
  • pedigree pattern of autosomal recessive trait
    »ó¿°»öü¼º ¿­¼ºÇüÁúÀÇ °¡°èµµ(¡­æëàõû¡òõ¡­Ê«Í§Óñ).
  • personality trait
    ÀÎ°ÝÆ¯¼º(¡­÷åàõ).
  • recessive trait
    ¿­¼ºÇüÁú(¡­û¡òõ).
  • sex linked trait
    ¹Ý¼ºÇüÁú.
  • sickle cell trait
    ÀûÇ÷±¸°â»óÇü¼º°æÇâ
  • sickle cell trait
    ÀûÇ÷±¸°â»óÇü¼º°æÇâ(îåúìϹÌÇßÒû¡à÷ÌËú¾).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • (Intermediate lacunar node)
    (Áß°£Ç÷°üÄ­¸²ÇÁÀý)
    [¿¾ ¿ë¾î] Áß°£¿ä¿ÍÀÓÆÄÀý
  • Lateral intermediate substance
    °¡ÂÊÁß°£È¸»öÁú
    [¿¾ ¿ë¾î] Áß°£Áú¿ÜÃøºÎ
  • Gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] °Å´ë¼¼Æ÷Áß°£¸Á»óüÇÙ
  • Posterior intermediate sulcus
    µÚÁß°£°í¶û
    [¿¾ ¿ë¾î] ÈÄÁß°£±¸
  • Medullary intermediate reticular nucleus
    ¼û³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] ¿¬¼öÁß°£¸Á»óüÇÙ
  • Intermediate hypothalamic region
    ½Ã»óÇϺÎÁß°£±¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺÎÁß°£ºÎ
  • Inferior pontine intermediate reticular nuleus
    ¾Æ·¡´Ù¸®³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] Çϱ³³úÁß°£¸Á»óüÇÙ
  • Superior pontine intermediate reticular nucleus
    À§´Ù¸®³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] »ó±³³úÁß°£¸Á»óüÇÙ
  • Intermediate
    Áß°£
    [¿¾ ¿ë¾î] Áß°£
  • Intermediate branch
    Áß°£°¡Áö
    [¿¾ ¿ë¾î] Áß°£Áö
  • Intermediate hepatic veins
    Áß°£°£Á¤¸Æ
    [¿¾ ¿ë¾î] Áß°£Á¤¸Æ
  • Intermediate zone
    Áß°£±¸¿ª
    [¿¾ ¿ë¾î] Áß°£´ë
  • Intermediate line
    Áß°£´É¼±
    [¿¾ ¿ë¾î] Áß°£¼±
  • Intermediate lymph nodes
    Áß°£¸²ÇÁÀý
    [¿¾ ¿ë¾î] Áß°£ÀÓÆÄÀý
  • Intermediate cervical septum
    Áß°£¸ñ»çÀ̸·
    [¿¾ ¿ë¾î] Áß°£°æºÎÁß°Ý
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • first intermediate host
    Á¦ÀÏÁß°£¼÷ÁÖ
  • intermediate host
    Áß°£¼÷ÁÖ
  • second intermediate host
    Á¦ÀÌÁß°£¼÷ÁÖ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle cell trait
    ³´¼¼Æ÷(á¬øà)¼ºÇâ(àõú¾)
  • common intermediate principle
    °øÅë Áß°£Ã¼¿ø¸®(Íì÷×ñéÊàô÷ê«×â)
  • covalent intermediate
    °øÀ¯°áÇÕ Áß°£»ê¹°(ÍìêóÌ¿ùêñéÊàß§Úª)
  • enzyme-substrate intermediate
    È¿¼Ò-±âÁú Áß°£Ã¼ (ý£áÈÐñòõñéÊàô÷)
  • intermediate
    Áß°£¹°(ñéÊàÚª)
  • lipid intermediate
    ÁöÁúÁß°£´ë»ç¹°(ò·òõñéÊàÓÛÞóÚª)
  • tetrahedral intermediate
    »ç¸éüÇü Áß°£´ë»ç¹° (ÞÌØüô÷û¡ñéÊàÓÛÞóÚª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trait
    Ư¼º, ¼ÒÁú, üÁú
  • intermediate
    Áß°£ÀÇ, Áß°£¹°
  • intermediate field MR scanner
    ÁßµîÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • intermediate nerve
    Áß°£½Å°æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IDL Index to Dental Literature; interface definition language; intermediate density lipoprotein; interme...
IF idiopathic fibroplasia; idiopathic flushing; immersion foot; immunofluorescence; indirect fluorescen...
IM idiopathic myelofibrosis; immunosuppressive method; implementation monitoring; Index Medicus; indome...
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
PBT Paul-Bunnell test; phenacetin breath test; piebald trait; profile-based therapy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
QTL Aquantitative trait locus
QTL Quantitative Trait Loci
QTLs Quantitative Trait Loci
SCT Sickle cell trait
STAXI State Trait Anger Expression Inventory
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • autosomal dominant trait
    »ó¿°»öü ¿ì¼º À¯Àü ÇüÁú
  • dominant trait
    ¿ì¼º ¼ÒÁú
  • pedigree pattern of autosomal dominant trait
    »ó¿°»öü¼º ¿ì¼º ÇüÁúÀÇ °¡°èµµ
  • qnantitative trait
    ÇüÁú
  • recessive trait
    ¿­¼º ÇüÁú
  • sex linked trait
    ¹Ý¼º ÇüÁú
  • sickle cell trait
    °â»ó ÀûÇ÷±¸ ¼ÒÁú
    »ê¼Ò ºÐ¾ÐÀÌ ³·Àºµ¥¼­ Æø·ÎµÈ ¶§ ÀûÇ÷±¸ÀÇ °â»óÈ­·Î ÀνĵǴ »ç¶÷ÀÇ »óÅÂ. °â»ó ÀûÇ÷±¸ ºóÇ÷°ú °ü°è°¡ ÀÖ´Â ´ë¸³À¯ÀüÀÚÀÇ ÇìÅ×·Î Á¢ÇÕ¿¡ ±âÀÎÇÑ´Ù.
  • sickle-cell trait
    ÀûÇ÷±¸ °â»óÇü¼º °æÇâ
  • corticotropin-like intermediate lobe peptide

    corticotropin-releasing factor (ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ¿ä¼Ò, ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ÀÎÀÚ

  • intermediate
    Áß°£ÀÇ, Áß°£¹°, Áß°£Ã¼, Áß°£¹°Áú
    1. ¾ç±Ø´ÜÀÇ ½Ö¹æ¿¡ ÀϺΠÀ¯»çÇÑ. 2. ¹ÝÀÀÀÇ ÃÖÁ¾ »ê¹° Çü¼º¿¡ ÇʼöÀûÀÎ È­ÇÐ ¹ÝÀÀÀÇ °úÁ¤ Áß¿¡ ¸¸µé¾îÁö´Â ¹°Áú.
  • intermediate body of Flemming
    Ç÷¹¹Ö Áß°£Ã¼
    À¯»ç ºÐ¿­ÀÇ ÃÖÁ¾ ´Ü°è¿¡ À־ µÎ °³ÀÇ ³¶ ¼¼Æ÷¸¦ ¿¬°á½ÃŰ´Â È£»ê¼º ¹°ÁúÀÇ ÀÛÀº Áö¸§ ´Ù¸®.
  • intermediate cell
    Áß°£ ¼¼Æ÷
    ÁßÃþ ÆíÆò »óÇÇ Á¶Á÷ÀÇ Áß°£Ãþ, ÁÖ·Î °ú¸³ ¼¼Æ÷ÃþÀ» Â÷ÁöÇÏ´Â ¼¼Æ÷·Î¼­ ¼¼ Æ÷Áø¿¡¼­´Â Ç¥Ãþ ¼¼Æ÷º¸´Ù ¾à°£ ÀÛ¾Æ 30-50 ¸¶ÀÌÅ©·Î¹ÌÅÍÀÇ ´Ù°¢ÇüÀ̳ª À¯¿øÇüÀÇ ¿¯Àº ¼¼Æ÷ÁúÀ» Áö´Ñ ÆíÆòÇÑ ¼¼Æ÷. ÇÙÀº ¼¼Æ÷ÀÇ Á߽ɿ¡ ÀÖÀ¸¸ç, Ç¥Ãþ ¼¼Æ÷º¸´Ù´Â ¾à°£ Å©°í, ¼ÒÆ÷»óÀÇ ÇÙ³» ±¸Á¶¸¦ °üÂûÇÒ ¼ö ÀÖ´Ù.
  • intermediate field MR scanner
    Áßµî ÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
  • intermediate junction
    ºÎÂø ¶ì
    µ¿ÀǾî=zonula adherens. Æó¼â ¶ìó·³ ¼¼Æ÷¸¦ ¿ÏÀüÈ÷ µÑ·¯ ½Î¸ç Æó¼â ¶ìÀÇ ¹Ù·Î ¾Æ·¡¿¡ À§Ä¡ÇÑ´Ù. ¼¼Æ÷ »çÀÌ¿¡ ÆøÀÌ 20-25§¬ÀÎ ÀÏÁ¤ÇÑ °ø°£ÀÌ Á¸ÀçÇϴµ¥ ÀÌ °ø°£Àº ÀüÀÚ ¹Ðµµ°¡ ³·¾Æ °ÅÀÇ Åõ¸íÇÏ°Ô º¸À̸ç ÀÌ ¾È¿¡ µé¾î ÀÖ´Â ¹°ÁúÀÌ µÎ °³ÀÇ ÇüÁú¸· ºÎÂø¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î ¹Ï¾îÁö³ª ¾ÆÁ÷ ¾î¶² ¹°ÁúÀÎÁö´Â ¹àÇôÁ® ÀÖÁö ¾Ê´Ù.
  • intermediate movement
    Áß°£ ÇÏ¾Ç ¿îµ¿
    ÇϾǰñÀÌ ¿îµ¿ÇÒ ¼ö ÀÖ´Â ÃÖ´ëÀÇ ¿îµ¿ ¹üÀ§ ³»¿¡¼­ ÀϾ´Â ¸ðµç ¿îµ¿.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
intermediate trait A measurable trait in which there is some evidence of the operation of a simple major cause, but in which the variation within the putative categories is such as to cause overlap and hence ambiguity in classification of any particular reading.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Bombay trait A rare recessive trait at a locus that ordinarily manufactures H substance, the precursor from which the A and B phenotypes are elaborated; the mutant causes failure to produce H substance and no matter what the genotype at the ABO locus, the phenotype is O. The Bombay phenomenon is epistatic to the ABO locus.
Origin: Bombay, India, where first reported
(05 Mar 2000)
galtonian trait A quantitative genetic trait due to contributions from many more of less equally important loci that resembles a continuous trait.
(05 Mar 2000)
recessive trait See: dominance of traits.
(05 Mar 2000)
marker trait A trait that may be of little importance in itself but which by association, linkage, or other means facilitates the detection, anticipation, or understanding of a disease or (for genetic diseases) the localization of the causative gene on the karyotype.
(05 Mar 2000)
categorical trait <genetics> A feature that can conveniently and effectively be analyzed by sorting into classes either because there is no satisfactory way of measuring it (as with blood groups) or because it falls into natural classes so that the variation among classes far exceeds that within classes (e.g., the phenotypic effects of many enzyme polymorphisms); existence of categories suggests but does not prove the operation of a major, simple, underlying cause.
Synonym: qualitative trait.
(05 Mar 2000)
penetrant trait A trait that in the appropriate genotypes is phenotypically manifest; strictly, it is the trait that is penetrant, not the gene.
See: penetrance.
(05 Mar 2000)
mendelian trait A categorical trait that segregates in accordance with a single-locus genetic system.
(05 Mar 2000)
chromosomal trait A trait dependent on a recurrent chromosomal aberration.
(05 Mar 2000)
codominant trait See: codominant.
(05 Mar 2000)
sickle cell trait <haematology> This condition occurs in people who have one of two possible genes (i.e., they are heterozygous forthe allele) that code for the defective haemoglobin responsible for sickle cell anaemia.
The coditionis diagnosed by exposing an individual's red blood cells to a low oxygen environment, if the trait is present, the cells will turn to a sickle shape. People with this trait may suffer milder symptoms of sickle cell anaemia, or may have no symptoms. Some scientists believe the trait actually provides an evolutionary advantage in tropical environments because the slightly altered shape of the blood cells causes a person to be more resistant to malaria.
(09 Oct 1997)
nonpenetrant trait A genetic trait that is not phenotypically manifest because of non-genetic factors it therefore does not include recessivity, epistasis, hypostasis, or parastasis but does include environmental factors and pure random effects such as lyonization.
(05 Mar 2000)
dominant lethal trait Trait, expressed in the phenotype if present in the genotype, that precludes having descendants. All such cases are necessarily sporadic and must represent new mutations as the usual methods of classical genetics provide no means of demonstrating any genetic component whatsoever, except for tenuous arguments such as advanced paternal age. Molecular biology may help although the methods may be tedious; if there is an epistatic gene that may mask the trait, the logic is more tractable, though complex.
(05 Mar 2000)
dominant trait An outstanding mental or physical characteristic.
See: dominance of traits.
(05 Mar 2000)
qualitative trait <genetics> A feature that can conveniently and effectively be analyzed by sorting into classes either because there is no satisfactory way of measuring it (as with blood groups) or because it falls into natural classes so that the variation among classes far exceeds that within classes (e.g., the phenotypic effects of many enzyme polymorphisms); existence of categories suggests but does not prove the operation of a major, simple, underlying cause.
Synonym: qualitative trait.
(05 Mar 2000)
quantitative trait A characteristic showing quantitative inheritance such as skin pigmentation in man.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • trait
    Ư¡, Ư¼º
  • culture trait
    ¹®È­Àû Ư¼º
  • trait
    Ư»ö;Ư¡;¾ó±¼ ¸ð½À
  • intermediate
    Áß°£¿¡ ÀÖ´Â
  • intermediate
    Áß°£ÀÇ;°³ÀçÇÏ´Â;Áß°£¿¡ ÀϾ´Â;Áß°£¹°;ÁßÀç(Áß°³)ÀÚ Áß°£½ÃÇè;ÁßÇüÂ÷;»çÀÌ¿¡ µé¾î°¡´Ù;ÁßÀçÇÏ´Ù;Áß°³ÇÏ´Ù
  • intermediate frequency
    Áß°£Á֯ļö
  • intermediate host
    Áß°£¼÷ÁÖ(±â»ýÃæÀÇ À¯»ý±âÀÇ ¼÷ÁÖ)
  • intermediate range ballistic missile
    Á߰Ÿ® ŸµµÅº
  • intermediate school
    ÁßÇб³;(¹Ì)±¹¹ÎÇб³4-6Çг⠰úÁ¤ÀÇ Çб³;(¿µ)±¹¹ÎÇб³ »ó±Þ°ú ÁßÇб³ÀÇ Áß°£Çб³(12-14¼¼ ÇлýÀ» ¼ö¿ë)
  • intermediate technology
    Áß°£ °øÇÐ(¼Ò±Ô¸ðÀûÀÌ°í °£´ÜÇÑ ¹æ¹ýÀ̳ª ±â¼úÀ» Çö´ëÀÇ Ã·´Ü ±â¼úÀ̳ª ±â°è¿¡ °áºÎ½ÃŲ °øÇÐ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á